Record Detail

 
PROGRAM SPONSORSHIP

Formal name of the incentive and/or reward program initiative (if applicable)

Program name PPO Pulse

Program sponsor(s) and parent organization of sponsor(s), if applicable

Program sponsor(s) Blue Cross of California - PPO Pulse P4P Program
Parent organization WellPoint Inc.

Primary program contact information

Name Jerry Low
Title Project Manager
Organization Blue Cross of California
Email jerry.low@wellpoint.com
Phone (818) 234-3798

Sponsoring organization type

Health Plan(s) Single PPO/other

Source of funding associated with program set-up costs

Funding source
Funded by program sponsor(s)

Percent contributed by sponsor and grant organization

% Sponsor 100
Program set-up costs 0

Source of funding associated with program operations costs

Funding source
Funded by program sponsor(s)

Percent contributed by sponsor and by grant organization

% Sponsor 100
Program operations cost 0

Start date & end date of the program

Start Date 6/5/2002
End ongoing

 
PROGRAM SCOPE

Geographic scope of program California
Individuals affected by program as a percentage of total population, if known
Employer/commercial health plan- active workers
(indicate %) na
Employer/commercial health plan- dependents
(indicate %) na
Employer/commercial health plan- retirees
(indicate %) na
Plan product(s) the program applies to (for plan sponsors only)
PPO

Direct target(s) of your program's incentives/rewards

Physician type
PCPs
Specialists
Indicate the specialities Family Practice, Internal Medicine, Obstetrics & Gynecology
Physician unit Individual physician/clinician
Recruitment of program targets
Mandatory- all members of target group that meet certain criteria
Specify Minimum number of patients for measures; Participation in certain health plan products; Location in targeted geographic area


PROGRAM PERFORMANCE MEASURES

Outpatient clinical and safety measures included in the program

Measure sources
Ambulatory care Quality Alliance (AQA)
HEDIS (clinical components)
Other
Specify Evidence-based medicine clinical measures developed internally or by consultants; SurveyAnswerTextNull

Measurement areas

Cardiac
Coronary artery disease (CAD)
Cancer screening
Breast
Cervical
Colon
Pulmonary
Adult Asthma
Pediatric Asthma
Safety
Appropriate antibiotic prescribing for infections
Other measurement areas
Diabetes
Hypertension
Adult Preventive Care
Pediatric Preventive Care

Resource Utilization and Cost

Resource utilization
Pharmaceutical usage- generic usage rate

Health plan performance measures

Performance measure weighting
Clinical performance
% or N/A 70
Cost
% or N/A 15
Other
Specify 15

Consumer measures

Additional details about your incentive/reward performance measurement mix CLINICAL QUALITY INDICATORS

Ace Inhibitor Use in CHF
Breast Cancer Screening
Cervical Cancer Screening
Childhood Immunizations: MMR
Childhood Immunizations: VZV
Chlamydia Screening
Colorectal Cancer Screening
Compliance with Lipid Lowering Drugs
Diabetes: Diabetic Retinal Exam
Diabetes: Glycosylated Hemoglobin Measured
Long-term Control Drugs for Asthma
Treatment of URI

GENERIC PRESCRIBING INDICATORS

Depression (SNRIs, SSRIs)
Hypertension (ACEI, ARBS, CCBs, BBs, Diuretic)
Hypercholesterolemia (HMGs)
Diabetes Metformin
Arthritis (NSAIDs, COX2s)
Ulcer (H2Ras, PPIs)

Data Reliability

Sources of data

Existing or new data Existing data sources
Data type
Administrative in origin (derived from claims data)
Data extracting entity
Program target
Data aggregator/analyzer
Program sponsor
Ensures data accuracy No
Risk-adjustment mechanisms used
Other
Specify Confidence Interval


INCENTIVE/REWARD CHARACTERISTICS

Start date & end date of the incentive/reward

Start Date 3/01/2004
End Date ongoing

Structure of the incentive or reward

Direct financial reward- increased payment
Percent of fees
Differential reimbursement for providers; (e.g., increase in rate of reimbursement)
Specify Increase in rate of reimbursement

Scoring used to determine payment

Absolute goals- patient level measures
Pay for meeting specific sub goals related to overall measure/group of measures
Absolute goals- population level measures
Pay for meeting specific sub goals related to overall measure/group of measures
Relative goals
Relative ranking to peer group on each measure
Frequency of reward or penalty
Annually
Time lag between measurement and receiving reward/penalty
Three - six months
Total dollar amounts awarded during the most recent calendar year 6%
Source of financial payments for meeting performance goals
Current budget redistributed

Shared savings breakdown (percentage should add to 100) if applicable

Additional details about the incentive/reward characteristics and scoring methodology OUR METHODOLOGY:

Identify all eligible patient or pharmacy cases to be counted for each indicator and each physician.
Calculate the physician’s score for each indicator.
Create a physician composite score calculating the percentage of time that the recommended care was delivered
across all indicators within the composite.
If the number of eligible cases within the composite score is greater than 35, then the following two steps are performed.
Compare the physician’s composite score to a specialty peer mean.
Rate the physician composite score using a 95 percent confidence interval. The composite is then assigned a rating based on a comparison to the specialty peer mean.


COLLABORATION CHARACTERISTICS

Phases of program where sought target collaboration
Did not seek collaboration
Receives compensation for administrative burden of data collection No
Characteristics of post-implementation target feedback
None of the above
Blinding of performance feedback with targets
Confidential
Results disclosed with comparison to benchmarks
Frequency of performance feedback to the targets
Semi-annual


PROGRAM EVALUATION

How the program evaluates its success
Improvements in clinical performance
An evaluation is not currently being conducted

 

© 2006 Leapfrog and Med-Vantage. Assisted by Booz Allen Hamilton and Discern Consulting.
Technical and design assistance by Raven Creative, Inc.